Robert L. Moore, Ph.D.

Robert L. Moore, Ph.D. has extensive experience in business development and sales. Robert L. began their career in 2005 as a Doctoral Candidate at Boston University, where they synthesized and tested novel histone-deacetylase inhibitors and other small molecule cancer therapeutics, and conducted chemical analysis of SIRT1 enzymatic activity in the regulation of the estrogen-response in breast cancer cells. In 2010, they became a Post-Doctoral Fellow at the Boston University School of Medicine, where they conducted chemical analysis and characterization of FOXO family protein enzymatic activity in the repression of estrogen-regulated gene activity, and synthesized novel small molecule FOXO family activators. In 2011, they joined Foresight Science & Technology as the Director of Business Development, where they built a new client base, managed employee training, and managed the company's life sciences group financials. From 2012 to 2014, they worked as Sales Director for Molecular MS Diagnostics, LLC and BioAgilytix Labs, and then as Sales Director for Cryoport from 2015 to 2018. In 2021, they took on the role of Vice President of Business Development for Shanghai Medicilon Inc. and Primera Analytical Solutions Corporation, and is currently the Vice President of Business Development for CubeWorks, Inc.

Robert L. Moore, Ph.D. began their educational career in 1999 when they earned a B.A. in Biology and a B.A. in East Asian Studies from Colby College. In 2005, they earned a Doctorate in Microbiology/Immunology from Boston University through a Dual Degree Program.